{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:41:13Z","timestamp":1777297273390,"version":"3.51.4"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10637-026-01606-2","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:46:34Z","timestamp":1770353194000},"page":"64-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The mechanistic role of Wilms tumor 1-associated protein in cancer pathogenesis, immunity, immunotherapy, and therapy resistance"],"prefix":"10.1007","volume":"44","author":[{"given":"Sarah Qutayba","family":"Badraldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karar H.","family":"Alfarttoosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder Naji","family":"Sameer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok Kumar","family":"Bishoyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Shankhyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashree","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab H.","family":"Athab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"3","key":"1606_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1606_CR2","doi-asserted-by":"publisher","first-page":"e1700","DOI":"10.1016\/s2214-109x(23)00406-0","volume":"11","author":"C Frick","year":"2023","unstructured":"Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F et al (2023) Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health 11(11):e1700\u2013e1712. https:\/\/doi.org\/10.1016\/s2214-109x(23)00406-0","journal-title":"Lancet Glob Health"},{"key":"1606_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1_1","volume":"1238","author":"R Kanwal","year":"2015","unstructured":"Kanwal R, Gupta K, Gupta S (2015) Cancer epigenetics: an introduction. Methods Mol Biol 1238:3\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-1804-1_1","journal-title":"Methods Mol Biol"},{"issue":"7","key":"1606_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A et al (2024) Embracing cancer complexity: hallmarks of systemic disease. Cell 187(7):1589\u20131616. https:\/\/doi.org\/10.1016\/j.cell.2024.02.009","journal-title":"Cell"},{"issue":"1","key":"1606_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01047-z","volume":"13","author":"F Sarno","year":"2021","unstructured":"Sarno F, Benincasa G, List M, Barabasi A-L, Baumbach J, Ciardiello F et al (2021) Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside. Clin Epigenetics 13(1):66. https:\/\/doi.org\/10.1186\/s13148-021-01047-z","journal-title":"Clin Epigenetics"},{"key":"1606_CR6","doi-asserted-by":"publisher","first-page":"1463847","DOI":"10.3389\/fimmu.2024.1463847","volume":"15","author":"X Qin","year":"2024","unstructured":"Qin X, Liu H, Zhang Q, Che Y, Lei T, Tang F et al (2024) RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints. Front Immunol 15:1463847","journal-title":"Front Immunol"},{"issue":"2","key":"1606_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","volume":"129","author":"Q Tang","year":"2023","unstructured":"Tang Q, Li L, Wang Y, Wu P, Hou X, Ouyang J et al (2023) RNA modifications in cancer. Br J Cancer 129(2):204\u2013221","journal-title":"Br J Cancer"},{"issue":"13","key":"1606_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C (2015) RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev 29(13):1343\u20131355. https:\/\/doi.org\/10.1101\/gad.262766.115","journal-title":"Genes Dev"},{"issue":"1","key":"1606_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02452-x","volume":"22","author":"S Wang","year":"2022","unstructured":"Wang S, Lv W, Li T, Zhang S, Wang H, Li X et al (2022) Dynamic regulation and functions of mRNA m6A modification. Cancer Cell Int 22(1):48. https:\/\/doi.org\/10.1186\/s12935-022-02452-x","journal-title":"Cancer Cell Int"},{"issue":"5","key":"1606_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J (2018) RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res 28(5):507\u2013517. https:\/\/doi.org\/10.1038\/s41422-018-0034-6","journal-title":"Cell Res"},{"issue":"2","key":"1606_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ et al (2014) Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res 24(2):177\u2013189. https:\/\/doi.org\/10.1038\/cr.2014.3","journal-title":"Cell Res"},{"issue":"2","key":"1606_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10620-024-08780-4","volume":"70","author":"W Tang","year":"2025","unstructured":"Tang W, Kong X, He S, Deng J, Mao M, Peng S et al (2025) WTAP regulates SOX1 expression to affect the tumorigenicity of colorectal cancer via an m6A-YTHDF2-dependent manner. Dig Dis Sci 70(2):598\u2013611. https:\/\/doi.org\/10.1007\/s10620-024-08780-4","journal-title":"Dig Dis Sci"},{"key":"1606_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108928","volume":"190","author":"W Ma","year":"2024","unstructured":"Ma W, Xu L, Wang Y, Chen S, Li D, Huo X et al (2024) Pir-27222 mediates PM(2.5)-induced lung cancer by resisting cell PANoptosis through the WTAP\/m(6)A axis. Environ Int 190:108928. https:\/\/doi.org\/10.1016\/j.envint.2024.108928","journal-title":"Environ Int"},{"issue":"1","key":"1606_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L et al (2021) N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 20(1):105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4","journal-title":"Mol Cancer"},{"issue":"3","key":"1606_CR15","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s12013-024-01342-5","volume":"82","author":"F Yu","year":"2024","unstructured":"Yu F, Feng Y, Wang Q, Sun J (2024) N(6)-methyladenosine (m(6)A) writer WTAP potentiates hepatocellular carcinoma immune evasion and aerobic glycolysis. Cell Biochem Biophys 82(3):2321\u20132331. https:\/\/doi.org\/10.1007\/s12013-024-01342-5","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"1606_CR16","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/cas.16136","volume":"115","author":"QZ Liu","year":"2024","unstructured":"Liu QZ, Zhang N, Chen JY, Zhou MJ, Zhou DH, Chen Z et al (2024) WTAP-induced N(6)-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer. Cancer Sci 115(6):1749\u20131762. https:\/\/doi.org\/10.1111\/cas.16136","journal-title":"Cancer Sci"},{"issue":"11","key":"1606_CR17","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41401-024-01309-5","volume":"45","author":"X-l Fu","year":"2024","unstructured":"Fu X-l, Guo S-m, Ma J-q, Ma F-y, Wang X, Tang Y-x et al (2024) HBXIP induces PARP1 via WTAP-mediated m6A modification and CEBPA-activated transcription in cisplatin resistance to hepatoma. Acta Pharmacol Sin 45(11):2405\u20132419. https:\/\/doi.org\/10.1038\/s41401-024-01309-5","journal-title":"Acta Pharmacol Sin"},{"key":"1606_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217254","volume":"604","author":"YT Tan","year":"2024","unstructured":"Tan YT, Li T, Wang RB, Liu ZK, Ma MY, Huang RZ et al (2024) WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Lett 604:217254. https:\/\/doi.org\/10.1016\/j.canlet.2024.217254","journal-title":"Cancer Lett"},{"issue":"8","key":"1606_CR19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300344RRR","volume":"37","author":"M Ye","year":"2023","unstructured":"Ye M, Chen J, Yu P, Hu C, Wang B, Bao J et al (2023) WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development. FASEB J 37(8):e23090. https:\/\/doi.org\/10.1096\/fj.202300344RRR","journal-title":"FASEB J"},{"issue":"1","key":"1606_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7150\/jca.102618","volume":"16","author":"S Liu","year":"2025","unstructured":"Liu S, Shang M, Gong J, Sun H, Hu B (2025) WTAP regulates mitochondrial damage and lipid oxidation in HCC by NOA1 mediated m6A modification. J Cancer 16(1):315\u2013330. https:\/\/doi.org\/10.7150\/jca.102618","journal-title":"J Cancer"},{"issue":"23","key":"1606_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70207","volume":"28","author":"XX Zhu","year":"2024","unstructured":"Zhu XX, Chen XY, Zhao LT, Zhang XL, Li YO, Shen XY (2024) WTAP-mediated m(6)A modification of circSMOC1 accelerates the tumorigenesis of non-small cell lung cancer by regulating miR-612\/CCL28 axis. J Cell Mol Med 28(23):e70207. https:\/\/doi.org\/10.1111\/jcmm.70207","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1606_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05035-y","volume":"12","author":"C-Q Wang","year":"2022","unstructured":"Wang C-Q, Tang C-H, Wang Y, Huang B-F, Hu G-N, Wang Q et al (2022) Upregulated WTAP expression appears to both promote breast cancer growth and inhibit lymph node metastasis. Sci Rep 12(1):1023. https:\/\/doi.org\/10.1038\/s41598-022-05035-y","journal-title":"Sci Rep"},{"issue":"11","key":"1606_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105301","volume":"299","author":"X Li","year":"2023","unstructured":"Li X, Liu C, Zhang Z, Li X, Yao Z, Dong Y et al (2023) Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2-ERK depending on downregulation of proteasome-related genes. J Biol Chem 299(11):105301. https:\/\/doi.org\/10.1016\/j.jbc.2023.105301","journal-title":"J Biol Chem"},{"issue":"1","key":"1606_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02391-5","volume":"41","author":"L Ding","year":"2022","unstructured":"Ding L, Wang R, Zheng Q, Shen D, Wang H, Lu Z et al (2022) CircPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA. J Exp Clin Cancer Res 41(1):187. https:\/\/doi.org\/10.1186\/s13046-022-02391-5","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1606_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-024-04321-7","volume":"50","author":"J Geng","year":"2025","unstructured":"Geng J, Shao Y, Pu Y, Wu Y, Yang Z (2025) Transcription factor CEBPD-mediated WTAP facilitates the stemness, growth, migration and glycolysis of glioblastoma stem like cells. Neurochem Res 50(2):100. https:\/\/doi.org\/10.1007\/s11064-024-04321-7","journal-title":"Neurochem Res"},{"issue":"6","key":"1606_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/s41375-023-01904-1","volume":"37","author":"YL Shao","year":"2023","unstructured":"Shao YL, Li YQ, Li MY, Wang LL, Zhou HS, Liu DH et al (2023) HIF1\u03b1-mediated transactivation of WTAP promotes AML cell proliferation via m(6)A-dependent stabilization of KDM4B mRNA. Leukemia 37(6):1254\u20131267. https:\/\/doi.org\/10.1038\/s41375-023-01904-1","journal-title":"Leukemia"},{"issue":"5","key":"1606_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101248","volume":"297","author":"K Horiuchi","year":"2021","unstructured":"Horiuchi K, Kawamura T, Hamakubo T (2021) Wilms\u2019 tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences. J Biol Chem 297(5):101248. https:\/\/doi.org\/10.1016\/j.jbc.2021.101248","journal-title":"J Biol Chem"},{"issue":"1","key":"1606_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-88671-4","volume":"15","author":"L Gao","year":"2025","unstructured":"Gao L, Gao J, He J, Fan W, Che X, Wang X et al (2025) Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastoma. Sci Rep 15(1):4412. https:\/\/doi.org\/10.1038\/s41598-025-88671-4","journal-title":"Sci Rep"},{"issue":"6","key":"1606_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20(6):303\u2013322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1606_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cr.2017.10","volume":"27","author":"A Li","year":"2017","unstructured":"Li A, Chen YS, Ping XL, Yang X, Xiao W, Yang Y et al (2017) Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res 27(3):444\u2013447. https:\/\/doi.org\/10.1038\/cr.2017.10","journal-title":"Cell Res"},{"issue":"7632","key":"1606_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature20568","volume":"540","author":"T Lence","year":"2016","unstructured":"Lence T, Akhtar J, Bayer M, Schmid K, Spindler L, Ho CH et al (2016) M(6)a modulates neuronal functions and sex determination in Drosophila. Nature 540(7632):242\u2013247. https:\/\/doi.org\/10.1038\/nature20568","journal-title":"Nature"},{"issue":"7481","key":"1606_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D et al (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481):117\u2013120. https:\/\/doi.org\/10.1038\/nature12730","journal-title":"Nature"},{"key":"1606_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M et al (2016) YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun 7:12626. https:\/\/doi.org\/10.1038\/ncomms12626","journal-title":"Nat Commun"},{"issue":"23","key":"1606_CR34","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1016\/j.molcel.2024.10.033","volume":"84","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, \u0106orovi\u0107 M, Hoch-Kraft P, Meiser N, Mesitov M, K\u00f6rtel N et al (2024) m6A sites in the coding region trigger translation-dependent mRNA decay. Mol Cell 84(23):4576\u201393.e12. https:\/\/doi.org\/10.1016\/j.molcel.2024.10.033","journal-title":"Mol Cell"},{"issue":"3","key":"1606_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2016.04.024","volume":"62","author":"U Schumann","year":"2016","unstructured":"Schumann U, Shafik A, Preiss T (2016) METTL3 gains R\/W access to the epitranscriptome. Mol Cell 62(3):323\u2013324. https:\/\/doi.org\/10.1016\/j.molcel.2016.04.024","journal-title":"Mol Cell"},{"issue":"2","key":"1606_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L et al (2014) A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10(2):93\u201395. https:\/\/doi.org\/10.1038\/nchembio.1432","journal-title":"Nat Chem Biol"},{"issue":"7620","key":"1606_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M et al (2016) M(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537(7620):369\u2013373. https:\/\/doi.org\/10.1038\/nature19342","journal-title":"Nature"},{"issue":"1","key":"1606_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG et al (2014) Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2032 sites. Cell Rep 8(1):284\u2013296. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.048","journal-title":"Cell Rep"},{"issue":"26","key":"1606_CR39","doi-asserted-by":"publisher","first-page":"17697","DOI":"10.1016\/S0021-9258(17)32497-3","volume":"269","author":"JA Bokar","year":"1994","unstructured":"Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F (1994) Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem 269(26):17697\u201317704","journal-title":"J Biol Chem"},{"issue":"1","key":"1606_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01810-0","volume":"10","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhang S, Xiong J, Xia T, Zhu R, Miao M et al (2024) The m(6)A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35. Cell Death Discov 10(1):43. https:\/\/doi.org\/10.1038\/s41420-024-01810-0","journal-title":"Cell Death Discov"},{"issue":"46","key":"1606_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317847121","volume":"121","author":"C Jaafar","year":"2024","unstructured":"Jaafar C, Aguiar RCT (2024) Dynamic multilayered control of m(6)A RNA demethylase activity. Proc Natl Acad Sci U S A 121(46):e2317847121. https:\/\/doi.org\/10.1073\/pnas.2317847121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1606_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110082","author":"K Chen","year":"2024","unstructured":"Chen K, Li W-D, Li X-Q (2024) The role of m6A in angiogenesis and vascular diseases. Iscience. https:\/\/doi.org\/10.1016\/j.isci.2024.110082","journal-title":"Iscience"},{"issue":"1","key":"1606_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1606_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gpb.2018.04.002","volume":"16","author":"S Liao","year":"2018","unstructured":"Liao S, Sun H, Xu C (2018) YTH domain: a family of N(6)-methyladenosine (m(6)A) readers. Genomics Proteomics Bioinformatics 16(2):99\u2013107. https:\/\/doi.org\/10.1016\/j.gpb.2018.04.002","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"7","key":"1606_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s11010-024-05040-x","volume":"479","author":"DH Zhu","year":"2024","unstructured":"Zhu DH, Su KK, Ou-Yang XX, Zhang YH, Yu XP, Li ZH et al (2024) Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers. Mol Cell Biochem 479(7):1553\u20131570. https:\/\/doi.org\/10.1007\/s11010-024-05040-x","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"1606_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.715","volume":"5","author":"Y Qu","year":"2024","unstructured":"Qu Y, Gao N, Zhang S, Gao L, He B, Wang C et al (2024) Role of N6\u2010methyladenosine RNA modification in cancer. MedComm 5(9):e715","journal-title":"MedComm"},{"issue":"1","key":"1606_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02148-y","volume":"23","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Man C, Zhu L, Zhang S, Wang X, Gong D et al (2024) R-loops\u2019 m6A modification and its roles in cancers. Mol Cancer 23(1):232. https:\/\/doi.org\/10.1186\/s12943-024-02148-y","journal-title":"Mol Cancer"},{"issue":"1","key":"1606_CR48","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s12035-024-04297-z","volume":"62","author":"X Liu","year":"2025","unstructured":"Liu X, Li Z, Tong J, Wu F, Jin H, Liu K (2025) Characterization of the expressions and m6A methylation modification patterns of mRNAs and lncRNAs in a spinal cord injury rat model. Mol Neurobiol 62(1):806\u2013818. https:\/\/doi.org\/10.1007\/s12035-024-04297-z","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1606_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26911","volume":"10","author":"S Gao","year":"2024","unstructured":"Gao S, Wang Y, Li X, Liang Y, Jin Z, Yang B et al (2024) Dynamics of N6-methyladenosine modification during Alzheimer\u2019s disease development. Heliyon 10(6):e26911. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26911","journal-title":"Heliyon"},{"issue":"6","key":"1606_CR50","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1101\/gr.278424.123","volume":"34","author":"S Feng","year":"2024","unstructured":"Feng S, Tellaetxe-Abete M, Zhang Y, Peng Y, Zhou H, Dong M et al (2024) Single-cell discovery of m(6)A RNA modifications in the hippocampus. Genome Res 34(6):822\u2013836. https:\/\/doi.org\/10.1101\/gr.278424.123","journal-title":"Genome Res"},{"key":"1606_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1271874","volume":"15","author":"D Ye","year":"2024","unstructured":"Ye D, Zhang Y, Zhang B, Liu J, Wei T, Lu S (2024) The regulatory role of m(6)A methylation modification in metabolic syndrome pathogenesis and progression. Front Physiol 15:1271874. https:\/\/doi.org\/10.3389\/fphys.2024.1271874","journal-title":"Front Physiol"},{"issue":"4","key":"1606_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.04.038","volume":"11","author":"H Hu","year":"2024","unstructured":"Hu H, Li Z, Xie X, Liao Q, Hu Y, Gong C et al (2024) Insights into the role of RNA m(6)A modification in the metabolic process and related diseases. Genes Dis 11(4):101011. https:\/\/doi.org\/10.1016\/j.gendis.2023.04.038","journal-title":"Genes Dis"},{"issue":"2","key":"1606_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108956","volume":"27","author":"R Chen","year":"2024","unstructured":"Chen R, Su F, Zhang T, Wu D, Yang J, Guan Q et al (2024) N6-methyladenosine modification of B7-H3 mRNA promotes the development and progression of colorectal cancer. iScience 27(2):108956. https:\/\/doi.org\/10.1016\/j.isci.2024.108956","journal-title":"iScience"},{"issue":"1","key":"1606_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-024-09959-1","volume":"41","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang X, Song H, Yuan J, Zhang X, Yuan Y et al (2024) M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-\u03b2catenin\/Hippo pathway. Cell Biol Toxicol 41(1):9. https:\/\/doi.org\/10.1007\/s10565-024-09959-1","journal-title":"Cell Biol Toxicol"},{"key":"1606_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1074307","volume":"12","author":"G Li","year":"2022","unstructured":"Li G, Fu Q, Liu C, Peng Y, Gong J, Li S et al (2022) The regulatory role of N6-methyladenosine RNA modification in gastric cancer: molecular mechanisms and potential therapeutic targets. Front Oncol 12:1074307. https:\/\/doi.org\/10.3389\/fonc.2022.1074307","journal-title":"Front Oncol"},{"issue":"1","key":"1606_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/abbs\/gmaa151","volume":"53","author":"H Liang","year":"2021","unstructured":"Liang H, Lin Z, Ye Y, Luo R, Zeng L (2021) ARRB2 promotes colorectal cancer growth through triggering WTAP. Acta Biochim Biophys Sin (Shanghai) 53(1):85\u201393. https:\/\/doi.org\/10.1093\/abbs\/gmaa151","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1606_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.973548","volume":"10","author":"JL Duan","year":"2022","unstructured":"Duan JL, Deng MH, Xiang ZC, Hu JL, Qu CH, Zhu TC et al (2022) Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: a cohort study with external extension analysis. Front Cell Dev Biol 10:973548. https:\/\/doi.org\/10.3389\/fcell.2022.973548","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"1606_CR58","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s12033-023-00834-8","volume":"66","author":"C-G Lv","year":"2024","unstructured":"Lv C-G, Cheng Y, Zhang L, Wu G-G, Liang C-Y, Tao Z et al (2024) EXOSC2 mediates the pro-tumor role of WTAP in breast cancer cells via activating the Wnt\/\u03b2-catenin signal. Mol Biotechnol 66(9):2569\u20132582. https:\/\/doi.org\/10.1007\/s12033-023-00834-8","journal-title":"Mol Biotechnol"},{"issue":"1","key":"1606_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06477-0","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Zheng F, Wang D, Yang Q (2024) Regulation of ULK1 by WTAP\/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell Death Dis 15(1):97. https:\/\/doi.org\/10.1038\/s41419-024-06477-0","journal-title":"Cell Death Dis"},{"issue":"7","key":"1606_CR60","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1007\/s00432-022-04320-7","volume":"149","author":"Y Liu","year":"2023","unstructured":"Liu Y, Da M (2023) Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-\u03b2 and enhances chemoradiotherapy resistance. J Cancer Res Clin Oncol 149(7):3977\u20133988. https:\/\/doi.org\/10.1007\/s00432-022-04320-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"1606_CR61","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.3390\/cimb46090612","volume":"46","author":"Y Deng","year":"2024","unstructured":"Deng Y, Li K, Yan W, Li K, Wang C (2024) Gene expression regulation and the signal transduction of programmed cell death. Curr Issues Molecul Biol 46(9):10264. https:\/\/doi.org\/10.3390\/cimb46090612","journal-title":"Curr Issues Molecul Biol"},{"issue":"1","key":"1606_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/iub.2410","volume":"73","author":"H Ma","year":"2021","unstructured":"Ma H, Shen L, Yang H, Gong H, Du X, Li J (2021) m6A methyltransferase Wilms\u2019 tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. IUBMB Life 73(1):108\u2013117. https:\/\/doi.org\/10.1002\/iub.2410","journal-title":"IUBMB Life"},{"issue":"5","key":"1606_CR63","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurpub\/ckz216","volume":"30","author":"C Mattiuzzi","year":"2020","unstructured":"Mattiuzzi C, Lippi G (2020) Cancer statistics: a comparison between world health organization (WHO) and global burden of disease (GBD). Eur J Public Health 30(5):1026\u20131027","journal-title":"Eur J Public Health"},{"issue":"1","key":"1606_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03289-2","volume":"24","author":"C Zhang","year":"2024","unstructured":"Zhang C, Chen J, Ren J, Li X, Zhang Y, Huang B et al (2024) N6-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer. Cancer Cell Int 24(1):96. https:\/\/doi.org\/10.1186\/s12935-024-03289-2","journal-title":"Cancer Cell Int"},{"issue":"4","key":"1606_CR65","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683\u2013691. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","journal-title":"Gut"},{"issue":"8","key":"1606_CR66","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300344RRR","volume":"37","author":"M Ye","year":"2023","unstructured":"Ye M, Chen J, Yu P, Hu C, Wang B, Bao J et al (2023) WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA\u2010mediated by YTHDC1 to promote colorectal cancer development. FASEB J 37(8):e23090","journal-title":"FASEB J"},{"issue":"29","key":"1606_CR67","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.2174\/0929867329666220922102949","volume":"30","author":"X Dai","year":"2023","unstructured":"Dai X, Chen K, Xie Y (2023) WTAP mediated the N6-methyladenosine modification of PDK4 to regulate the malignant behaviors of colorectal cancer cells in vitro and in vivo. Curr Med Chem 30(29):3368\u20133381. https:\/\/doi.org\/10.2174\/0929867329666220922102949","journal-title":"Curr Med Chem"},{"issue":"12","key":"1606_CR68","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.62347\/qaqe4354","volume":"16","author":"J Han","year":"2024","unstructured":"Han J, Zhang J, Shi H, Wen X (2024) WTAP knockdown inhibits cell migration through regulating SNAIL1 expression in colorectal cancer. Am J Transl Res 16(12):8023\u20138031. https:\/\/doi.org\/10.62347\/qaqe4354","journal-title":"Am J Transl Res"},{"issue":"4","key":"1606_CR69","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.4081\/ejh.2024.4145","volume":"68","author":"M Relucenti","year":"2024","unstructured":"Relucenti M, Tito C, Mercantini P, Pilozzi E, Barbaranelli C, Cristiano L, Savarese D, Bastianelli D, Fazi F, Petrozza V, Li X (2024) High WTAP expression level as a promising biomarker for poor prognosis in colorectal cancer: a pilot study. Eur J Histochem: EJH 68(4):4145. https:\/\/doi.org\/10.4081\/ejh.2024.4145","journal-title":"Eur J Histochem: EJH"},{"issue":"3","key":"1606_CR70","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/cancers14030621","volume":"14","author":"B Cucarull","year":"2022","unstructured":"Cucarull B, Tutusaus A, Rider P, Hernaez-Alsina T, Cuno C, Garcia de Frutos P, Colell A, Mari M, Morales A (2022) Hepatocellular carcinoma: molecular pathogenesis and therapeutic advances. Cancers 14(3):621","journal-title":"Cancers"},{"issue":"6","key":"1606_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060656","volume":"14","author":"R-M Szilveszter","year":"2024","unstructured":"Szilveszter R-M, Muntean M, Florea A (2024) Molecular mechanisms in tumorigenesis of hepatocellular carcinoma and in target treatments\u2014an overview. Biomolecules 14(6):656","journal-title":"Biomolecules"},{"key":"1606_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116365","volume":"173","author":"H Ma","year":"2024","unstructured":"Ma H, Hong Y, Xu Z, Weng Z, Yang Y, Jin D et al (2024) N6-methyladenosine (m6A) modification in hepatocellular carcinoma. Biomed Pharmacother 173:116365","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1606_CR73","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","volume":"32","author":"KK-L Kwan","year":"2024","unstructured":"Kwan KK-L, Seoung D-H, Chin DW-C, Ng IO-L, Wong CC-L, Wong C-M (2024) N6-methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer. Mol Ther 32(12):4435\u20134447","journal-title":"Mol Ther"},{"issue":"1","key":"1606_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, Chen D, Yang B, He B et al (2019) WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer 18(1):127. https:\/\/doi.org\/10.1186\/s12943-019-1053-8","journal-title":"Mol Cancer"},{"key":"1606_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852000","volume":"12","author":"L Liang","year":"2022","unstructured":"Liang L, Xu H, Dong Q, Qiu L, Lu L, Yang Q et al (2022) WTAP is correlated with unfavorable prognosis, tumor cell proliferation, and immune infiltration in hepatocellular carcinoma. Front Oncol 12:852000. https:\/\/doi.org\/10.3389\/fonc.2022.852000","journal-title":"Front Oncol"},{"key":"1606_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003468","author":"Z Sun","year":"2025","unstructured":"Sun Z, Li J, Zhang Z, Liu P, Wang R, Song Z et al (2025) WTAP-mediated m6A modification of JUNB contributes to poor prognosis of HCC patients through the NLRP3-GSDMD pathway. Chin Med J. https:\/\/doi.org\/10.1097\/cm9.0000000000003468","journal-title":"Chin Med J"},{"issue":"8","key":"1606_CR77","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong K-K (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14(8):535\u2013546","journal-title":"Nat Rev Cancer"},{"key":"1606_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.thromres.2022.10.020","volume":"221","author":"B Bj\u00f8rnhart","year":"2023","unstructured":"Bj\u00f8rnhart B, Kristiansen C, Asmussen J, Hansen KH, Wedervang K, J\u00f8rgensen TL et al (2023) Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy. Thromb Res 221:164\u2013172","journal-title":"Thromb Res"},{"key":"1606_CR79","doi-asserted-by":"publisher","DOI":"10.4065\/83.3.355","author":"T Sher","year":"2008","unstructured":"Sher T, Dy GK, Adjei AA (2008) Small cell lung cancer. Mayo Clinic Proceed Elsev. https:\/\/doi.org\/10.4065\/83.3.355","journal-title":"Mayo Clinic Proceed Elsev"},{"issue":"1","key":"1606_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01240-5","volume":"20","author":"L Weng","year":"2020","unstructured":"Weng L, Qiu K, Gao W, Shi C, Shu F (2020) LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP. BMC Pulm Med 20(1):213. https:\/\/doi.org\/10.1186\/s12890-020-01240-5","journal-title":"BMC Pulm Med"},{"key":"1606_CR81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2022.02.041","volume":"605","author":"H Cheng","year":"2022","unstructured":"Cheng H, Wang SJ, Li Z, Ma Y, Song YR (2022) ING2-WTAP is a potential therapeutic target in non-small cell lung cancer. Biochem Biophys Res Commun 605:31\u201338. https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.041","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1606_CR82","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/coc.0000000000001116","volume":"47","author":"C Liu","year":"2024","unstructured":"Liu C, Gao F, Yang J, Liu C, Tian Z (2024) Wilms\u2019 tumor 1-associating protein promotes nonsmall-cell lung cancer through the expression of carcinoembryonic antigen-related cell adhesion molecule 5. Am J Clin Oncol 47(10):465\u2013474. https:\/\/doi.org\/10.1097\/coc.0000000000001116","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"1606_CR83","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A et al (2022) Breast cancer statistics, 2022. CA Cancer J Clin 72(6):524\u2013541. https:\/\/doi.org\/10.3322\/caac.21754","journal-title":"CA Cancer J Clin"},{"issue":"10286","key":"1606_CR84","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (2021) Breast cancer. Lancet 397(10286):1750\u20131769","journal-title":"Lancet"},{"issue":"8","key":"1606_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04028-5","volume":"12","author":"B Ou","year":"2021","unstructured":"Ou B, Liu Y, Yang X, Xu X, Yan Y, Zhang J (2021) C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Cell Death Dis 12(8):737. https:\/\/doi.org\/10.1038\/s41419-021-04028-5","journal-title":"Cell Death Dis"},{"issue":"1","key":"1606_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02058-4","volume":"10","author":"M Dragonetti","year":"2024","unstructured":"Dragonetti M, Turco C, Benedetti A, Goeman F, Forcato M, Scalera S et al (2024) The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell Death Discov 10(1):276","journal-title":"Cell Death Discov"},{"issue":"2","key":"1606_CR87","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s10528-023-10423-8","volume":"62","author":"M Tan","year":"2024","unstructured":"Tan M, He Y, Yi J, Chen J, Guo Q, Liao N et al (2024) WTAP mediates NUPR1 regulation of LCN2 through m6A modification to influence ferroptosis, thereby promoting breast cancer proliferation, migration and invasion. Biochem Genet 62(2):876\u2013891. https:\/\/doi.org\/10.1007\/s10528-023-10423-8","journal-title":"Biochem Genet"},{"issue":"3","key":"1606_CR88","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1606_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04949-8","volume":"42","author":"A W\u00e9ber","year":"2024","unstructured":"W\u00e9ber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P et al (2024) Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol 42(1):237","journal-title":"World J Urol"},{"issue":"5","key":"1606_CR90","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ (2024) Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol 21(5):389\u2013400","journal-title":"Nat Rev Clin Oncol"},{"issue":"16","key":"1606_CR91","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1002\/cam4.2560","volume":"8","author":"A Chandra","year":"2019","unstructured":"Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S et al (2019) Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med 8(16):7018\u20137031","journal-title":"Cancer Med"},{"key":"1606_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.819183","volume":"10","author":"K Hossain","year":"2022","unstructured":"Hossain K, Escobar Bermeo J, Warton K, Valenzuela S (2022) New approaches and biomarker candidates for the early detection of ovarian cancer. Front Bioeng Biotechnol 10:819183","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"1606_CR93","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA (2023) Clinical and translational advances in ovarian cancer therapy. Nat Cancer 4(9):1239\u20131257","journal-title":"Nat Cancer"},{"key":"1606_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6130806","volume":"2022","author":"Y Lyu","year":"2022","unstructured":"Lyu Y, Zhang Y, Wang Y, Luo Y, Ding H, Li P et al (2022) HIF-1\u03b1 regulated WTAP overexpression promoting the Warburg effect of ovarian cancer by m6A-dependent manner. J Immunol Res 2022:6130806. https:\/\/doi.org\/10.1155\/2022\/6130806","journal-title":"J Immunol Res"},{"issue":"12","key":"1606_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07257-6","volume":"15","author":"R Hou","year":"2024","unstructured":"Hou R, Sun X, Cao S, Wang Y, Jiang L (2024) Stabilization of SQLE mRNA by WTAP\/FTO\/IGF2BP3-dependent manner in HGSOC: implications for metabolism, stemness, and progression. Cell Death Dis 15(12):872. https:\/\/doi.org\/10.1038\/s41419-024-07257-6","journal-title":"Cell Death Dis"},{"issue":"3","key":"1606_CR96","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"1606_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1355551","volume":"14","author":"B Lu","year":"2024","unstructured":"Lu B, Liu Y, Yao Y, Yang T, Zhang H, Yang X et al (2024) Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications. Front Oncol 14:1355551","journal-title":"Front Oncol"},{"issue":"2","key":"1606_CR98","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/tox.24031","volume":"39","author":"P Zhao","year":"2024","unstructured":"Zhao P, Han P, Ma Y, Tian P, Li J (2024) Circ_0082878 contributes to prostate cancer progression via the miR-455-3p\/WTAP axis. Environ Toxicol 39(2):979\u2013990. https:\/\/doi.org\/10.1002\/tox.24031","journal-title":"Environ Toxicol"},{"issue":"1","key":"1606_CR99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329. https:\/\/doi.org\/10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1606_CR100","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2188\/jea.je20120162","volume":"23","author":"Y Lin","year":"2013","unstructured":"Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J et al (2013) Epidemiology of esophageal cancer in Japan and China. J Epidemiol 23(4):233\u2013242. https:\/\/doi.org\/10.2188\/jea.je20120162","journal-title":"J Epidemiol"},{"issue":"5","key":"1606_CR101","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v6.i5.112","volume":"6","author":"KJ Napier","year":"2014","unstructured":"Napier KJ, Scheerer M, Misra S (2014) Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 6(5):112\u2013120. https:\/\/doi.org\/10.4251\/wjgo.v6.i5.112","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"1606_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04001-0","volume":"21","author":"Y Gao","year":"2023","unstructured":"Gao Y, Yuan L, Ke C, Pei Z, Liu X, Wu R et al (2023) Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP. J Transl Med 21(1):159. https:\/\/doi.org\/10.1186\/s12967-023-04001-0","journal-title":"J Transl Med"},{"issue":"7","key":"1606_CR103","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/cas.15924","volume":"115","author":"J Zou","year":"2024","unstructured":"Zou J, Ma Q, Gao C, Yang M, Wen J, Xu L et al (2024) WTAP promotes proliferation of esophageal squamous cell carcinoma via m(6)A-dependent epigenetic promoting of PTP4A1. Cancer Sci 115(7):2254\u20132268. https:\/\/doi.org\/10.1111\/cas.15924","journal-title":"Cancer Sci"},{"issue":"4","key":"1606_CR104","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4149\/neo_2024_231219N653","volume":"71","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang X, Zhang Y, Wu J, Li J, Shan B (2024) WTAP\/CCND1 axis accelerates esophageal squamous cell carcinoma progression by MAPK signaling pathway. Neoplasma 71(4):359\u2013373. https:\/\/doi.org\/10.4149\/neo_2024_231219N653","journal-title":"Neoplasma"},{"issue":"1","key":"1606_CR105","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1606_CR106","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75(1):74\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.036","journal-title":"Eur Urol"},{"issue":"4","key":"1606_CR107","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S et al (2022) European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82(4):399\u2013410. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.006","journal-title":"Eur Urol"},{"issue":"1","key":"1606_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0706-6","volume":"37","author":"J Tang","year":"2018","unstructured":"Tang J, Wang F, Cheng G, Si S, Sun X, Han J et al (2018) Wilms\u2019 tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability. J Exp Clin Cancer Res 37(1):40. https:\/\/doi.org\/10.1186\/s13046-018-0706-6","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"1606_CR109","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1002\/cam4.4157","volume":"10","author":"L He","year":"2021","unstructured":"He L, Chen S, Ying Y, Xie H, Li J, Ma X et al (2021) MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP. Cancer Med 10(20):7222\u20137232. https:\/\/doi.org\/10.1002\/cam4.4157","journal-title":"Cancer Med"},{"issue":"1","key":"1606_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76326-9","volume":"14","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Chen X, Wang H, Ding L, Wang M, Li G et al (2024) WTAP-dependent N6-methyladenosine methylation of lncRNA TEX41 promotes renal cell carcinoma progression. Sci Rep 14(1):24742. https:\/\/doi.org\/10.1038\/s41598-024-76326-9","journal-title":"Sci Rep"},{"issue":"1","key":"1606_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01456-y","volume":"40","author":"AS Doghish","year":"2024","unstructured":"Doghish AS, Abd-Elmawla MA, Hatawsh A, Zaki MB, Aborehab NM, Radwan AF et al (2024) Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential. Metab Brain Dis 40(1):42. https:\/\/doi.org\/10.1007\/s11011-024-01456-y","journal-title":"Metab Brain Dis"},{"key":"1606_CR112","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae268","author":"J Qiu","year":"2024","unstructured":"Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y et al (2024) O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae268","journal-title":"Neuro Oncol"},{"issue":"8","key":"1606_CR113","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L (2020) The global burden of urinary bladder cancer: an update. World J Urol 38(8):1895\u20131904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4","journal-title":"World J Urol"},{"issue":"3-4","key":"1606_CR114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","volume":"28","author":"K Wang","year":"2023","unstructured":"Wang K, Wang G, Li G, Zhang W, Wang Y, Lin X et al (2023) m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis 28(3\u20134):627\u2013638. https:\/\/doi.org\/10.1007\/s10495-023-01817-5","journal-title":"Apoptosis"},{"issue":"24","key":"1606_CR115","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/0008-5472.Can-21-1518","volume":"81","author":"W Wei","year":"2021","unstructured":"Wei W, Sun J, Zhang H, Xiao X, Huang C, Wang L et al (2021) Circ0008399 interaction with WTAP promotes assembly and activity of the m(6)A methyltransferase complex and promotes cisplatin resistance in bladder cancer. Cancer Res 81(24):6142\u20136156. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1518","journal-title":"Cancer Res"},{"key":"1606_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B (2025) Ferroptosis and immunotherapy: breaking barriers in cancer treatment resistance. Crit Rev Oncol Hematol 214:104907. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104907","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"1606_CR117","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY et al (2019) Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med 381(12):1124\u20131135. https:\/\/doi.org\/10.1056\/NEJMoa1905287","journal-title":"N Engl J Med"},{"issue":"6","key":"1606_CR118","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41418-021-00905-w","volume":"29","author":"Z-X Li","year":"2022","unstructured":"Li Z-X, Zheng Z-Q, Yang P-Y, Lin L, Zhou G-Q, Lv J-W et al (2022) WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis. Cell Death Differ 29(6):1137\u20131151. https:\/\/doi.org\/10.1038\/s41418-021-00905-w","journal-title":"Cell Death Differ"},{"issue":"11","key":"1606_CR119","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"2","key":"1606_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E et al (2021) Acute myeloid leukemia: current progress and future directions. Blood Cancer J 11(2):41. https:\/\/doi.org\/10.1038\/s41408-021-00425-3","journal-title":"Blood Cancer J"},{"issue":"1","key":"1606_CR121","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05299-9","volume":"81","author":"A Iaiza","year":"2024","unstructured":"Iaiza A, Mazzanti G, Goeman F, Cesaro B, Cortile C, Corleone G et al (2024) WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells. Cell Mol Life Sci 81(1):276. https:\/\/doi.org\/10.1007\/s00018-024-05299-9","journal-title":"Cell Mol Life Sci"},{"key":"1606_CR122","doi-asserted-by":"crossref","unstructured":"Gao X-N, Li Y-Q, Liu D, Wang L, Shao Y-L, Zhou H-S, et al (2024) WTAP-mediated m6A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t (8; 21) AML. 2024.","DOI":"10.21203\/rs.3.rs-4756131\/v1"},{"issue":"6","key":"1606_CR123","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH (2021) Systemic immunity in cancer. Nat Rev Cancer 21(6):345\u2013359. https:\/\/doi.org\/10.1038\/s41568-021-00347-z","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1606_CR124","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.trecan.2021.04.002","volume":"7","author":"S Suresh","year":"2021","unstructured":"Suresh S, O\u2019Donnell KA (2021) Translational control of immune evasion in cancer. Trends Cancer 7(7):580\u2013582. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.002","journal-title":"Trends Cancer"},{"key":"1606_CR125","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/641079","volume":"2012","author":"MH Manjili","year":"2012","unstructured":"Manjili MH, Egilmez N, Knutson KL, Selvan SR, Ostberg JR (2012) Tumor escape and progression under immune pressure. Clin Dev Immunol 2012:641079. https:\/\/doi.org\/10.1155\/2012\/641079","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"1606_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2019.08.002","volume":"35","author":"M Abbott","year":"2019","unstructured":"Abbott M, Ustoyev Y (2019) Cancer and the immune system: the history and background of immunotherapy. Semin Oncol Nurs 35(5):150923. https:\/\/doi.org\/10.1016\/j.soncn.2019.08.002","journal-title":"Semin Oncol Nurs"},{"key":"1606_CR127","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2021.5","volume":"23","author":"MM Gonzales Carazas","year":"2021","unstructured":"Gonzales Carazas MM, Pinto JA, Casado FL (2021) Biological bases of cancer immunotherapy. Expert Rev Mol Med 23:e3. https:\/\/doi.org\/10.1017\/erm.2021.5","journal-title":"Expert Rev Mol Med"},{"issue":"17","key":"1606_CR128","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE et al (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373(17):1627\u20131639. https:\/\/doi.org\/10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"key":"1606_CR129","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","volume":"35","author":"KE Beckermann","year":"2017","unstructured":"Beckermann KE, Dudzinski SO, Rathmell JC (2017) Dysfunctional T cell metabolism in the tumor microenvironment. Cytokine Growth Factor Rev 35:7\u201314. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.04.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"26","key":"1606_CR130","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690","journal-title":"N Engl J Med"},{"key":"1606_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1007696","volume":"13","author":"J Lei","year":"2022","unstructured":"Lei J, Fan Y, Yan C, Jiamaliding Y, Tang Y, Zhou J et al (2022) Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. Front Genet 13:1007696. https:\/\/doi.org\/10.3389\/fgene.2022.1007696","journal-title":"Front Genet"},{"issue":"6","key":"1606_CR132","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.18632\/aging.205666","volume":"16","author":"Q Ji","year":"2024","unstructured":"Ji Q, Guo Y, Li Z, Zhang X (2024) WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma. Aging (Albany NY) 16(6):5601\u20135617. https:\/\/doi.org\/10.18632\/aging.205666","journal-title":"Aging (Albany NY)"},{"key":"1606_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.06.019","author":"Q Chen","year":"2024","unstructured":"Chen Q, Ao L, Zhao Q, Tang L, Xiong Y, Yuan Y et al (2024) WTAP\/YTHDF1-mediated m(6)A modification amplifies IFN-\u03b3-induced immunosuppressive properties of human MSCs. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2024.06.019","journal-title":"J Adv Res"},{"key":"1606_CR134","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cytogfr.2025.06.007","volume":"84","author":"J Gao","year":"2025","unstructured":"Gao J, Zhang X, Liu Y, Gu X (2025) Ferroptosis in immune cells: implications for tumor immunity and cancer therapy. Cytokine Growth Factor Rev 84:59\u201373. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.06.007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"1606_CR135","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e6","volume":"25","author":"N Jang","year":"2025","unstructured":"Jang N, Kim IK, Jung D, Chung Y, Kang YP (2025) Regulation of ferroptosis in cancer and immune cells. Immune Netw 25(1):e6. https:\/\/doi.org\/10.4110\/in.2025.25.e6","journal-title":"Immune Netw"},{"key":"1606_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179451","author":"A Ramos","year":"2021","unstructured":"Ramos A, Sadeghi S, Tabatabaeian H (2021) Battling chemoresistance in cancer: root causes and strategies to uproot them. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22179451","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1606_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan XY (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9(1):175. https:\/\/doi.org\/10.1038\/s41392-024-01856-7","journal-title":"Signal Transduct Target Ther"},{"key":"1606_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.598344","volume":"11","author":"W Xie","year":"2021","unstructured":"Xie W, Liu N, Wang X, Wei L, Xie W, Sheng X (2021) Wilms\u2019 tumor 1-associated protein contributes to chemo-resistance to cisplatin through the Wnt\/\u03b2-catenin pathway in endometrial cancer. Front Oncol 11:598344. https:\/\/doi.org\/10.3389\/fonc.2021.598344","journal-title":"Front Oncol"},{"key":"1606_CR139","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.02.043","volume":"451","author":"BQ Li","year":"2019","unstructured":"Li BQ, Liang ZY, Seery S, Liu QF, You L, Zhang TP et al (2019) WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. Cancer Lett 451:48\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2019.02.043","journal-title":"Cancer Lett"},{"key":"1606_CR140","doi-asserted-by":"crossref","unstructured":"Liu Y, Li W, Yang J, Ma W, Fan C, Da M. Wilms tumor 1 associated protein promotes metastasis and chemo-resistance to oxaliplatin by nuclear factor kappa B pathway in gastric cancer. 2023.","DOI":"10.21203\/rs.3.rs-2448436\/v1"},{"issue":"1","key":"1606_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03120-w","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang B, Wang Y, Wang W, Wang Z, Zhang Y, Pan X et al (2024) WTAP\/IGF2BP3 mediated m6A modification of the EGR1\/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells. J Exp Clin Cancer Res 43(1):204. https:\/\/doi.org\/10.1186\/s13046-024-03120-w","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1606_CR142","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4143\/crt.2022.1600","volume":"56","author":"P Cao","year":"2024","unstructured":"Cao P, Zhang W, Qiu J, Tang Z, Xue X, Feng T (2024) Gemcitabine inhibits the progression of pancreatic cancer by restraining the WTAP\/MYC chain in an m6A-dependent manner. Cancer Res Treat 56(1):259\u2013271. https:\/\/doi.org\/10.4143\/crt.2022.1600","journal-title":"Cancer Res Treat"},{"issue":"6586","key":"1606_CR143","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M et al (2022) Early detection of cancer. Science 375(6586):eaay9040. https:\/\/doi.org\/10.1126\/science.aay9040","journal-title":"Science"},{"key":"1606_CR144","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.2147\/ott.S205730","volume":"12","author":"HL Yu","year":"2019","unstructured":"Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH (2019) WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. Onco Targets Ther 12:6191\u20136201. https:\/\/doi.org\/10.2147\/ott.S205730","journal-title":"Onco Targets Ther"},{"key":"1606_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154114","volume":"238","author":"G Luo","year":"2022","unstructured":"Luo G, Qi Y, Lei Z, Shen X, Chen M, Du L et al (2022) A potential biomarker of esophageal squamous cell carcinoma WTAP promotes the proliferation and migration of ESCC. Pathol Res Pract 238:154114. https:\/\/doi.org\/10.1016\/j.prp.2022.154114","journal-title":"Pathol Res Pract"},{"key":"1606_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.973548","volume":"10","author":"J-L Duan","year":"2022","unstructured":"Duan J-L, Deng M-H, Xiang Z-C, Hu J-L, Qu C-H, Zhu T-C et al (2022) Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: a cohort study with external extension analysis. Front Cell Dev Biol 10:973548","journal-title":"Front Cell Dev Biol"},{"key":"1606_CR147","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae268","author":"J Qiu","year":"2024","unstructured":"Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y et al (2024) O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro-oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae268","journal-title":"Neuro-oncol"},{"issue":"1","key":"1606_CR148","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00280-023-04533-8","volume":"92","author":"L Hong","year":"2023","unstructured":"Hong L, Wang X, Zheng L, Wang S, Zhu G (2023) Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16\/CXCR6 axis. Cancer Chemother Pharmacol 92(1):71\u201381. https:\/\/doi.org\/10.1007\/s00280-023-04533-8","journal-title":"Cancer Chemother Pharmacol"},{"issue":"20","key":"1606_CR149","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/0008-5472.Can-21-0494","volume":"81","author":"J Deng","year":"2021","unstructured":"Deng J, Zhang J, Ye Y, Liu K, Zeng L, Huang J et al (2021) N(6) -methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression. Cancer Res 81(20):5268\u20135283. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0494","journal-title":"Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01606-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-026-01606-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01606-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:53:59Z","timestamp":1777294439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-026-01606-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1007\/s10637-026-01606-2","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}